211 related articles for article (PubMed ID: 24675993)
1. Ethanol lock therapy (E-Lock) in the prevention of catheter-related bloodstream infections (CR-BSI) after major heart surgery (MHS): a randomized clinical trial.
Pérez-Granda MJ; Barrio JM; Muñoz P; Hortal J; Rincón C; Rabadán PM; Pernia MS; Bouza E
PLoS One; 2014; 9(3):e91838. PubMed ID: 24675993
[TBL] [Abstract][Full Text] [Related]
2. Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial.
Souweine B; Lautrette A; Gruson D; Canet E; Klouche K; Argaud L; Bohe J; Garrouste-Orgeas M; Mariat C; Vincent F; Cayot S; Cointault O; Lepape A; Guelon D; Darmon M; Vesin A; Caillot N; Schwebel C; Boyer A; Azoulay E; Bouadma L; Timsit JF
Am J Respir Crit Care Med; 2015 May; 191(9):1024-32. PubMed ID: 25668557
[TBL] [Abstract][Full Text] [Related]
3. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial.
Slobbe L; Doorduijn JK; Lugtenburg PJ; El Barzouhi A; Boersma E; van Leeuwen WB; Rijnders BJ
PLoS One; 2010 May; 5(5):e10840. PubMed ID: 20520776
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections.
Kayton ML; Garmey EG; Ishill NM; Cheung NK; Kushner BH; Kramer K; Modak S; Rossetto C; Hennelly C; Doyle MP; Rosenberg S; Santoro O; La Quaglia MP
J Pediatr Surg; 2010 Oct; 45(10):1961-6. PubMed ID: 20920713
[TBL] [Abstract][Full Text] [Related]
5. Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: A randomised controlled multi-centre trial.
Schoot RA; van Ommen CH; Stijnen T; Tissing WJ; Michiels E; Abbink FC; Raphael MF; Heij HA; Lieverst JA; Spanjaard L; Zwaan CM; Caron HN; van de Wetering MD
Eur J Cancer; 2015 Sep; 51(14):2031-8. PubMed ID: 26188849
[TBL] [Abstract][Full Text] [Related]
6. Ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients with intestinal failure: preliminary experience.
Wales PW; Kosar C; Carricato M; de Silva N; Lang K; Avitzur Y
J Pediatr Surg; 2011 May; 46(5):951-6. PubMed ID: 21616259
[TBL] [Abstract][Full Text] [Related]
7. Treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial.
Wolf J; Connell TG; Allison KJ; Tang L; Richardson J; Branum K; Borello E; Rubnitz JE; Gaur AH; Hakim H; Su Y; Federico SM; Mechinaud F; Hayden RT; Monagle P; Worth LJ; Curtis N; Flynn PM
Lancet Infect Dis; 2018 Aug; 18(8):854-863. PubMed ID: 29884572
[TBL] [Abstract][Full Text] [Related]
8. Ethanol lock therapy for catheter-associated blood stream infections in a pediatric intensive care unit.
Valentine KM
Pediatr Crit Care Med; 2011 Nov; 12(6):e292-6. PubMed ID: 21499184
[TBL] [Abstract][Full Text] [Related]
9. Adverse effects associated with ethanol catheter lock solutions: a systematic review.
Mermel LA; Alang N
J Antimicrob Chemother; 2014 Oct; 69(10):2611-9. PubMed ID: 24891431
[TBL] [Abstract][Full Text] [Related]
10. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
[TBL] [Abstract][Full Text] [Related]
11. Central catheter-associated bloodstream infection reduction with ethanol lock prophylaxis in pediatric intestinal failure: broadening quality improvement initiatives from hospital to home.
Ardura MI; Lewis J; Tansmore JL; Harp PL; Dienhart MC; Balint JP
JAMA Pediatr; 2015 Apr; 169(4):324-31. PubMed ID: 25642912
[TBL] [Abstract][Full Text] [Related]
12. A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients--the HEALTHY-CATH trial.
Broom JK; Krishnasamy R; Hawley CM; Playford EG; Johnson DW
BMC Nephrol; 2012 Nov; 13():146. PubMed ID: 23121768
[TBL] [Abstract][Full Text] [Related]
13. Blood culture differential time to positivity enables safe catheter retention in suspected catheter-related bloodstream infection: a randomized controlled trial.
Sabatier C; García X; Ferrer R; Duarte M; Colomina M; Alcaráz D; Fontanals D; Vallés J
Med Intensiva; 2015 Apr; 39(3):135-41. PubMed ID: 24661917
[TBL] [Abstract][Full Text] [Related]
14. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
15. Ethanol locks for the prevention of catheter-related infection in patients with central venous catheter: A systematic review and meta-analysis of randomized controlled trials.
Zhang J; Wang B; Wang J; Yang Q
PLoS One; 2019; 14(9):e0222408. PubMed ID: 31513652
[TBL] [Abstract][Full Text] [Related]
16. A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison.
Picardi M; Della Pepa R; Cerchione C; Pugliese N; Mortaruolo C; Trastulli F; Giordano C; Grimaldi F; Zacheo I; Raimondo M; Chiurazzi F; Pane F
Clin Lymphoma Myeloma Leuk; 2019 Apr; 19(4):e184-e194. PubMed ID: 30704933
[TBL] [Abstract][Full Text] [Related]
17. Effects of 70% ethanol locks on rates of central line infection, thrombosis, breakage, and replacement in pediatric intestinal failure.
Abu-El-Haija M; Schultz J; Rahhal RM
J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):703-8. PubMed ID: 24590214
[TBL] [Abstract][Full Text] [Related]
18. Dialysis Catheter-Related Bloodstream Infections: A Cluster-Randomized Trial of the ClearGuard HD Antimicrobial Barrier Cap.
Hymes JL; Mooney A; Van Zandt C; Lynch L; Ziebol R; Killion D
Am J Kidney Dis; 2017 Feb; 69(2):220-227. PubMed ID: 27839894
[TBL] [Abstract][Full Text] [Related]
19. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
[TBL] [Abstract][Full Text] [Related]
20. Systematic Review and Meta-Analysis of the Utilization of Ethanol Locks in Pediatric Patients With Intestinal Failure.
Rahhal R; Abu-El-Haija MA; Fei L; Ebach D; Orkin S; Kiscaden E; Cole CR
JPEN J Parenter Enteral Nutr; 2018 May; 42(4):690-701. PubMed ID: 28767319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
